Actuant Corporation (ATU)
(Delayed Data from NYSE)
$25.82 USD
+0.62 (2.46%)
Updated May 3, 2019 04:02 PM ET
After-Market: $25.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$25.82 USD
+0.62 (2.46%)
Updated May 3, 2019 04:02 PM ET
After-Market: $25.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
What's in Store for Zebra Technologies (ZBRA) in Q1 Earnings?
by Zacks Equity Research
Solid order backlog and strong end market demand for its leading portfolio of solutions will aid Zebra Technologies' (ZBRA) first- quarter results.
Manufacturing Tools Industry's Near-Term Outlook Lacks Luster
by Payal Jalan
Technological advancement in manufacturing processes, infrastructural investments and tax policy changes favor industrial tool makers. Forex issues, tariffs and commodity inflation are the drags.
iRobot Poised on Solid Demand in Key Markets Amid Risks
by Zacks Equity Research
Robust sales of Roomba e5 and Roomba i7 in the overseas end markets will drive iRobot's (IRBT) growth. However, the company faces stiff competition in U.S. robotic vacuum cleaning market.
Here's Why it is Worth Investing in Actuant (ATU) Stock Now
by Zacks Equity Research
Actuant (ATU) is poised to gain on product development, operational efficiency and portfolio restructuring measures.
Actuant (ATU) Beats Q2 Earnings, Misses Revenue Estimates
by Zacks Equity Research
Actuant's (ATU) second-quarter fiscal 2019 adjusted earnings increase year over year on solid growth in operating profit and improved margins.
Actuant (ATU) Q2 Earnings Beat Estimates
by Zacks Equity Research
Actuant (ATU) delivered earnings and revenue surprises of 11.76% and -0.15%, respectively, for the quarter ended February 2019. Do the numbers hold clues to what lies ahead for the stock?
Actuant (ATU) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Actuant (ATU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Actuant to Divest Segment, Focus on Industrial Tool Business
by Zacks Equity Research
Divesture of EC&S segment will enable Actuant (ATU) to become a pure play industrial tools and services company and provide higher returns to shareholders.
Actuant (ATU) Up 10.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Actuant (ATU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alcoa (AA) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Initiatives to reduce complexities of operations and strengthen balance sheet are expected to be conducive to Alcoa's (AA) fourth-quarter results. However, higher raw material costs remain a concern.
Actuant Gains From Inorganic Moves, Cost Concerns Prevail
by Zacks Equity Research
Actuant (ATU) gains from solid sales, pricing initiatives and inorganic initiatives. However, rising cost remains a cause of worry.
Actuant (ATU) Beats Q1 Earnings Estimates, Lowers Sales View
by Zacks Equity Research
Actuant's (ATU) first-quarter fiscal 2019 results gain from organic sales growth and rise in margins. The company maintains earnings projection for fiscal 2019 while revises down sales estimates.
Actuant (ATU) Q1 Earnings Beat Estimates
by Zacks Equity Research
Actuant (ATU) delivered earnings and revenue surprises of 12.50% and -2.15%, respectively, for the quarter ended November 2018. Do the numbers hold clues to what lies ahead for the stock?
Actuant (ATU) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Actuant (ATU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Near-Term Outlook Bleak for Manufacturing Tools Industry
by Zacks Equity Research
Improving manufacturing activities, housing market, infrastructural development and rising adoption of e-retailing are boons for tool makers. Tariffs, forex woes and high labor costs are concerning.
Actuant Gains From Solid Sales, Rising Cost Remains a Drag
by Zacks Equity Research
Stellar end-market sales and acquisition benefits will likely boost Actuant's near-term results. However, rising cost remains a major drag.
New Strong Sell Stocks for October 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Why Is Actuant (ATU) Down 15.3% Since Last Earnings Report?
by Zacks Equity Research
Actuant (ATU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for October 24th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Stanley Black & Decker Banking on Buyouts Amid Cost Woes
by Zacks Equity Research
Stanley Black & Decker (SWK) is poised to grow on the back of increased sales and new business acquisitions. However, escalating cost remains a major drag.
New Strong Sell Stocks for October 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for October 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Should You Get Rid of Actuant (ATU) Now?
by Zacks Equity Research
Actuant (ATU) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Champions Oncology, Actuant, Caterpillar and Boeing highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Champions Oncology, Actuant, Caterpillar and Boeing highlighted as Zacks Bull and Bear of the Day
Bear Of The Day: Actuant (ATU)
by Brian Bolan
Despite a recent beat, the stock and estimates have fallen for this stock. When estimates fall like they have a stock can become the Bear Of The Day.